Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript
Biotricity (OTCMKTS:BTCY - Get Free Report) and 111 (NASDAQ: YI - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation. Analyst Ratings This is a breakdown of recent ratings
Three Healthcare IT stocks have surged over 20% in 2025, driven by growth in telehealth, remote monitoring and value-based care platforms.
| Biotechnology Industry | Healthcare Sector | Waqaas Al-Siddiq CEO | OTC PINK Exchange | 09074H203 CUSIP |
| US Country | 46 Employees | - Last Dividend | 3 Jul 2023 Last Split | 18 Feb 2016 IPO Date |
Biotricity, Inc. is a pioneering medical technology company based in Redwood City, California, focused on the development and delivery of cutting-edge biometric data monitoring solutions. Catering to the United States' medical, healthcare, and consumer markets, Biotricity is committed to enhancing the diagnosis and management of lifestyle and chronic diseases through innovative remote monitoring technologies. By leveraging advanced biometric data analysis, the company aims to bridge the gap between patient and healthcare providers, enabling real-time, accurate health monitoring and fostering a proactive approach to health management.
An integrated ECG (Electrocardiogram) device designed for continuous, real-time monitoring and transmission of patients' cardiac activity. Bioflux is particularly beneficial for diagnosing and managing heart-related disorders by providing healthcare professionals with detailed, actionable insights into their patients' cardiac health.
This sophisticated software component works in tandem with the Bioflux device, analyzing and synthesizing the collected ECG monitoring data. It utilizes advanced algorithms to identify and interpret significant cardiac events, ensuring accurate diagnoses and facilitating effective treatment planning. The software embodies Biotricity's commitment to enhancing the capabilities of remote health monitoring systems.